Johnson & Johnson said on Thursday it will discontinue a late-stage study of an experimental E.coli vaccine it was developing ...

A new journal purports to improve the publishing process through open access and public peer review, but it was co-founded by ...

A survey of the nation's oncologists showed that professional burnout has reached a new high (59% vs 45% in 2013), and fewer ...

Patients with advanced kidney cancer who received an experimental vaccine after their tumors were removed were still ...